vs

Side-by-side financial comparison of Reservoir Media, Inc. (RSVR) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

Reservoir Media, Inc. is the larger business by last-quarter revenue ($45.6M vs $35.5M, roughly 1.3× RECURSION PHARMACEUTICALS, INC.). Reservoir Media, Inc. runs the higher net margin — 4.8% vs -304.2%, a 309.1% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs 7.7%). Reservoir Media, Inc. produced more free cash flow last quarter ($12.8M vs $-47.3M). Over the past eight quarters, RECURSION PHARMACEUTICALS, INC.'s revenue compounded faster (60.5% CAGR vs 7.9%).

Reservoir Media, Inc. is a leading global independent music rights management company. It owns and administers extensive catalogs of recorded music, music publishing copyrights, and neighboring rights, partnering with top songwriters, performing artists, and producers across genres including pop, hip-hop, rock, and film soundtracks. It licenses its content for use across streaming platforms, advertising, film and television productions, live events, and other commercial channels, with operations spanning North America, Europe, and Asia Pacific markets.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

RSVR vs RXRX — Head-to-Head

Bigger by revenue
RSVR
RSVR
1.3× larger
RSVR
$45.6M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+674.0% gap
RXRX
681.7%
7.7%
RSVR
Higher net margin
RSVR
RSVR
309.1% more per $
RSVR
4.8%
-304.2%
RXRX
More free cash flow
RSVR
RSVR
$60.1M more FCF
RSVR
$12.8M
$-47.3M
RXRX
Faster 2-yr revenue CAGR
RXRX
RXRX
Annualised
RXRX
60.5%
7.9%
RSVR

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
RSVR
RSVR
RXRX
RXRX
Revenue
$45.6M
$35.5M
Net Profit
$2.2M
$-108.1M
Gross Margin
64.5%
59.8%
Operating Margin
22.7%
-304.8%
Net Margin
4.8%
-304.2%
Revenue YoY
7.7%
681.7%
Net Profit YoY
-58.1%
39.6%
EPS (diluted)
$0.03
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RSVR
RSVR
RXRX
RXRX
Q4 25
$45.6M
$35.5M
Q3 25
$45.4M
$5.2M
Q2 25
$37.2M
$19.2M
Q1 25
$41.4M
$14.7M
Q4 24
$42.3M
$4.5M
Q3 24
$40.7M
$26.1M
Q2 24
$34.3M
$14.4M
Q1 24
$39.1M
$13.8M
Net Profit
RSVR
RSVR
RXRX
RXRX
Q4 25
$2.2M
$-108.1M
Q3 25
$2.3M
$-162.3M
Q2 25
$-555.7K
$-171.9M
Q1 25
$2.7M
$-202.5M
Q4 24
$5.2M
$-178.9M
Q3 24
$185.0K
$-95.8M
Q2 24
$-346.7K
$-97.5M
Q1 24
$2.8M
$-91.4M
Gross Margin
RSVR
RSVR
RXRX
RXRX
Q4 25
64.5%
59.8%
Q3 25
63.6%
-183.8%
Q2 25
64.5%
-4.9%
Q1 25
65.6%
-48.0%
Q4 24
64.4%
-181.4%
Q3 24
63.5%
53.7%
Q2 24
61.3%
36.2%
Q1 24
63.4%
19.1%
Operating Margin
RSVR
RSVR
RXRX
RXRX
Q4 25
22.7%
-304.8%
Q3 25
23.5%
-3327.6%
Q2 25
14.7%
-916.8%
Q1 25
25.2%
-1297.9%
Q4 24
22.6%
-4042.4%
Q3 24
24.9%
-377.1%
Q2 24
14.5%
-697.4%
Q1 24
22.4%
-698.4%
Net Margin
RSVR
RSVR
RXRX
RXRX
Q4 25
4.8%
-304.2%
Q3 25
5.0%
-3135.3%
Q2 25
-1.5%
-894.2%
Q1 25
6.4%
-1373.3%
Q4 24
12.4%
-3935.5%
Q3 24
0.5%
-367.5%
Q2 24
-1.0%
-676.6%
Q1 24
7.1%
-662.4%
EPS (diluted)
RSVR
RSVR
RXRX
RXRX
Q4 25
$0.03
$-0.17
Q3 25
$0.03
$-0.36
Q2 25
$-0.01
$-0.41
Q1 25
$-0.50
Q4 24
$0.08
$-0.56
Q3 24
$-0.34
Q2 24
$-0.01
$-0.40
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RSVR
RSVR
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$20.6M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$373.6M
$1.1B
Total Assets
$941.9M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RSVR
RSVR
RXRX
RXRX
Q4 25
$20.6M
$743.3M
Q3 25
$27.9M
$659.8M
Q2 25
$14.9M
$525.1M
Q1 25
$21.4M
$500.5M
Q4 24
$17.8M
$594.4M
Q3 24
$21.1M
$427.6M
Q2 24
$16.4M
$474.3M
Q1 24
$18.1M
$296.3M
Total Debt
RSVR
RSVR
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
RSVR
RSVR
RXRX
RXRX
Q4 25
$373.6M
$1.1B
Q3 25
$370.9M
$1.0B
Q2 25
$368.9M
$919.1M
Q1 25
$364.9M
$933.9M
Q4 24
$359.5M
$1.0B
Q3 24
$357.9M
$524.6M
Q2 24
$353.0M
$584.4M
Q1 24
$353.0M
$401.2M
Total Assets
RSVR
RSVR
RXRX
RXRX
Q4 25
$941.9M
$1.5B
Q3 25
$903.5M
$1.4B
Q2 25
$857.0M
$1.3B
Q1 25
$865.1M
$1.3B
Q4 24
$832.4M
$1.4B
Q3 24
$778.2M
$726.5M
Q2 24
$768.2M
$775.9M
Q1 24
$783.5M
$557.8M
Debt / Equity
RSVR
RSVR
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RSVR
RSVR
RXRX
RXRX
Operating Cash FlowLast quarter
$12.9M
$-46.1M
Free Cash FlowOCF − Capex
$12.8M
$-47.3M
FCF MarginFCF / Revenue
28.1%
-133.1%
Capex IntensityCapex / Revenue
0.3%
3.5%
Cash ConversionOCF / Net Profit
5.89×
TTM Free Cash FlowTrailing 4 quarters
$50.1M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RSVR
RSVR
RXRX
RXRX
Q4 25
$12.9M
$-46.1M
Q3 25
$19.3M
$-117.4M
Q2 25
$6.0M
$-76.4M
Q1 25
$12.2M
$-132.0M
Q4 24
$11.2M
$-115.4M
Q3 24
$13.3M
$-59.2M
Q2 24
$8.6M
$-82.2M
Q1 24
$13.8M
$-102.3M
Free Cash Flow
RSVR
RSVR
RXRX
RXRX
Q4 25
$12.8M
$-47.3M
Q3 25
$19.2M
$-117.6M
Q2 25
$6.0M
$-79.6M
Q1 25
$12.2M
$-133.8M
Q4 24
$11.2M
$-116.7M
Q3 24
$13.3M
$-63.8M
Q2 24
$8.5M
$-83.4M
Q1 24
$13.8M
$-109.0M
FCF Margin
RSVR
RSVR
RXRX
RXRX
Q4 25
28.1%
-133.1%
Q3 25
42.2%
-2272.5%
Q2 25
16.1%
-413.9%
Q1 25
29.3%
-907.4%
Q4 24
26.5%
-2567.7%
Q3 24
32.7%
-244.6%
Q2 24
24.9%
-578.5%
Q1 24
35.2%
-789.9%
Capex Intensity
RSVR
RSVR
RXRX
RXRX
Q4 25
0.3%
3.5%
Q3 25
0.3%
4.7%
Q2 25
0.1%
16.4%
Q1 25
0.1%
12.4%
Q4 24
0.0%
28.6%
Q3 24
0.1%
17.5%
Q2 24
0.1%
8.2%
Q1 24
0.0%
48.2%
Cash Conversion
RSVR
RSVR
RXRX
RXRX
Q4 25
5.89×
Q3 25
8.54×
Q2 25
Q1 25
4.56×
Q4 24
2.14×
Q3 24
71.97×
Q2 24
Q1 24
4.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RSVR
RSVR

Other$18.9M42%
Recorded Music Segment$12.9M28%
Performance$6.2M14%
Synchronization$4.6M10%
Physical$1.9M4%
Neighboring Rights$1.1M3%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons